A detailed history of Met Life Investment Management, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 24,536 shares of PRCT stock, worth $2.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
24,536
Previous 24,536 -0.0%
Holding current value
$2.18 Million
Previous $1.5 Million 31.17%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$45.73 - $69.19 $185,663 - $280,911
4,060 Added 19.83%
24,536 $1.5 Million
Q1 2024

May 14, 2024

BUY
$40.38 - $50.75 $826,820 - $1.04 Million
20,476 New
20,476 $1.01 Million
Q4 2023

Feb 14, 2024

BUY
$24.89 - $43.41 $53,314 - $92,984
2,142 Added 11.16%
21,336 $894,000
Q3 2023

May 09, 2024

BUY
$30.02 - $38.81 $161,987 - $209,418
5,396 Added 39.11%
19,194 $629,000
Q2 2023

Apr 29, 2024

BUY
$26.7 - $37.02 $512,479 - $710,561
19,194 New
19,194 $678,000
Q2 2023

Aug 10, 2023

BUY
$26.7 - $37.02 $144,073 - $199,759
5,396 Added 39.11%
19,194 $678,000
Q1 2023

May 09, 2024

BUY
$26.64 - $39.74 $367,578 - $548,332
13,798 New
13,798 $392 Million
Q2 2022

May 10, 2024

BUY
$29.23 - $44.45 $256,931 - $390,715
8,790 Added 175.52%
13,798 $451,000
Q2 2022

Mar 22, 2023

BUY
$29.23 - $44.45 $256,931 - $390,715
8,790 Added 175.52%
13,798 $451,000
Q2 2022

Aug 11, 2022

BUY
$29.23 - $44.45 $256,931 - $390,715
8,790 Added 175.52%
13,798 $451,000
Q1 2022

May 10, 2024

BUY
$16.89 - $35.74 $84,585 - $178,985
5,008 New
5,008 $175,000
Q1 2022

Jun 20, 2023

SELL
$16.89 - $35.74 $148,463 - $314,154
-8,790 Reduced 63.7%
5,008 $175,000
Q1 2022

Mar 22, 2023

SELL
$16.89 - $35.74 $148,463 - $314,154
-8,790 Reduced 63.7%
5,008 $175,000
Q1 2022

May 12, 2022

BUY
$16.89 - $35.74 $84,585 - $178,985
5,008 New
5,008 $175,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.97B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.